Mechanistic modeling of tumor immune microenvironment reveals strategies to enhance antibody-drug conjugates’ efficacy
Constantinos Harkos, Lance L Munn, Triantafyllos Stylianopoulos, Rakesh K Jain · 2026
Read Mechanistic modeling of tumor immune microenvironment reveals strategies to enhance antibody-drug conjugates’ efficacy by Constantinos Harkos, Lance L Munn, Triantafyllos Stylianopoulos, Rakesh K Jain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13536119.txt.
Description
Constantinos Harkos and co-authors build a math model of how antibody-drug conjugates move through a tumor and meet immune cells. These drugs pair a targeted antibody with a cell killing or immune tuning payload. The 2026 study centers on one such drug aimed at PD-L1, a protein on tumor cells.
The model folds in blood flow, fluid pressure in tissue, drug binding, and the growth of killer T cells in lymph nodes. It was fit to mouse data from two tumor types and three treatments. The model matched the finding that the paired drug beat its parts alone. It also predicts drug and cell patterns that tests did not directly track.
Catalog record
| CREATOR | Constantinos Harkos, Lance L Munn, Triantafyllos Stylianopoulos, Rakesh K Jain |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |